Candida albicans and cancer: Can this yeast induce cancer development or progression?
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
There is currently increasing concern about the relation between microbial infections and cancer. More and more studies support the view that there is an association, above all, when the causal agents are bacteria or viruses. This review adds to this, summarizing evidence that the opportunistic fungus Candida albicans increases the risk of carcinogenesis and metastasis. Until recent years, Candida spp. had fundamentally been linked to cancerous processes as it is an opportunist pathogen that takes advantage of the immunosuppressed state of patients particularly due to chemotherapy. In contrast, the most recent findings demonstrate that C. albicans is capable of promoting cancer by several mechanisms, as described in the review: production of carcinogenic byproducts, triggering of inflammation, induction of Th17 response and molecular mimicry. We underline the need not only to control this type of infection during cancer treatment, especially given the major role of this yeast species in nosocomial infections, but also to find new therapeutic approaches to avoid the pro-tumor effect of this fungal species.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718 · cited 2×
“This occurs, for example, in colorectal cancer due to Fusobacterium spp. (Keku et al., 2013; Kostic et al., 2013; McCoy et al., 2013; Rubinstein et al., 2013), and in hepatocellular carcinoma due to HBV (Na et al., 2011) and EBV (Baumforth et al., 2008; Chetaille et al., 2009; Heller et al., 2008)…”
BackgroundRubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476 · cited 1×
“This occurs, for example, in colorectal cancer due to Fusobacterium spp. (Keku et al., 2013; Kostic et al., 2013; McCoy et al., 2013; Rubinstein et al., 2013), and in hepatocellular carcinoma due to HBV (Na et al., 2011) and EBV (Baumforth et al., 2008; Chetaille et al., 2009; Heller et al., 2008)…”
BackgroundInnate Immunity: The Virtues of a Nonclonal System of Recognition
Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434 · cited 1×
“…the microorganisms is accomplished by pattern recognition receptors (PRRs), which recognize conserved structures called pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs; Gauglitz et al., 2012; Janeway, 1989; Medzhitov & Janeway, 1997; Mogensen, 2009).”
BackgroundInflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828 · cited 2×
“It is known that Th17 cells produce IL-17, which is required for resistance against C. albicans (Acosta-Rodriguez et al., 2007; Huang et al., 2004; LeibundGut-Landmann et al., 2007).”
BackgroundSchwabe, R. F., & Jobin, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3610 · Cited by 1,689
LeibundGut-Landmann, S., Groß, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E., Tybulewicz, V., Brown, G. D., Ruland, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1460 · Cited by 1,191 · cited 1×
“It is known that Th17 cells produce IL-17, which is required for resistance against C. albicans (Acosta-Rodriguez et al., 2007; Huang et al., 2004; LeibundGut-Landmann et al., 2007).”
BackgroundIL-23 promotes tumour incidence and growth
Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018 · cited 2×
“Moreover, this cytokine antagonizes IL-12 and IFN-g, both of which are crucial in Th1-type antitumor immune responses (Langowski et al., 2006, 2007).”
Background
Research works printed but not linked: 132
- 10.1038/nri1391 · DOI · Paper page
- 10.1016/j.cell.2006.02.015 · DOI · Paper page
- 10.1128/JCM.43.4.1829-1835.2005 · DOI · Paper page
- Anttila V, 1994, Clin Infect Dis, 18, 979, 10.1093/clinids/18.6.979 · DOI
- 10.1086/589516 · DOI · Paper page
- 10.2353/ajpath.2008.070845 · DOI · Paper page
- Belperio J, 2000, J Leukoc Biol, 68, 1, 10.1189/jlb.68.1.1 · DOI · Paper page
- Berg M, 2006, Eur J Immunol, 36, 2960, 10.1002/eji.200636033 · DOI · Paper page
- Blasi E, 2005, FEMS Immunol Med Microbiol, 44, 69, 10.1016/j.femsim.2004.12.005 · DOI · Paper page
- Boehme A, 2009, Ann Hematol, 88, CP6
- Boettcher JP, 2011, Dig Dis, 29, 384, 10.1159/000329801 · DOI · Paper page
- 10.1084/jem.20020470 · DOI · Paper page
- Bugarcic A, 2008, Glycobiology, 18, 679, 10.1093/glycob/cwn046 · DOI · Paper page
- 10.1074/jbc.M709334200 · DOI · Paper page
- Cawson RA, 1969, Proc R Soc Med, 62, 610
- 10.1182/blood-2008-07-168096 · DOI · Paper page
- Cisterna R, 2010, J Clin Microbiol, 48, 4200, 10.1128/JCM.00920-10 · DOI · Paper page
- 10.1099/mic.0.046326-0 · DOI · Paper page
- 10.1038/nature01322 · DOI · Paper page
- de Jong MAWP, 2010, Mol Immunol, 47, 1216, 10.1016/j.molimm.2009.12.016 · DOI · Paper page
- de Pauw B, 2004, J Antimicrob Chemother, 53, 130, 10.1093/jac/dkh085 · DOI
- 10.1200/JCO.2005.03.9594 · DOI · Paper page
- Falkensammer B, 2007, Mycoses, 50, 172, 10.1111/j.1439-0507.2006.01353.x · DOI
- Filler S, 1996, Infect Immun, 64, 2609, 10.1128/IAI.64.7.2609-2617.1996 · DOI · Paper page
- Filler SG, 2006, Curr Opin Microbiol, 9, 333, 10.1016/j.mib.2006.06.005 · DOI
- Gainza-Cirauqui ML, 2013, J Oral Pathol Med, 42, 243, 10.1111/j.1600-0714.2012.01203.x · DOI
- Gauglitz GG, 2012, Acta Derm Venereol, 92, 291, 10.2340/00015555-1250 · DOI
- Gilmore BJ, 1988, J Infect Dis, 157, 38, 10.1093/infdis/157.1.38 · DOI · Paper page
- Girmenia C, 2004, J Med Microbiol, 53, 103, 10.1099/jmm.0.05297-0 · DOI
- 10.1128/IAI.69.5.2815-2820.2001 · DOI · Paper page
- 10.1038/nature07965 · DOI · Paper page
- 10.1128/IAI.00518-09 · DOI · Paper page
- Gustafson KS, 1991, J Clin Invest, 87, 1896, 10.1172/JCI115214 · DOI · Paper page
- Haghnegahdar H, 2000, J Leukoc Biol, 67, 53, 10.1002/jlb.67.1.53 · DOI · Paper page
- Heller KN, 2008, Int J Cancer, 123, 2824, 10.1002/ijc.23845 · DOI
- 10.1016/j.chom.2009.05.002 · DOI · Paper page
- Hooper SJ, 2009, Head Neck, 31, 1228, 10.1002/hed.21140 · DOI · Paper page
- Hostetter MK, 1996, Trends Microbiol, 4, 242, 10.1016/0966-842X(96)10036-6 · DOI
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994). Schistosomes, Liver Flukes and Helicobacter pylori. In: World Health Organization International Agency for Research on Cancer, ed. IARC Monographs on the evaluation of carcinogenic risks to humans, vol. 61. Lyon: IARC, 177–240
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1999). Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. In: World Health Organization International Agency for Research on Cancer, ed. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol. 77. Lyon: IARC, 319–35
- 10.1101/SQB.1989.054.01.003 · DOI · Paper page
- 10.4049/jimmunol.1201715 · DOI · Paper page
- 10.1086/375784 · DOI · Paper page
- 10.4049/jimmunol.177.7.4679 · DOI · Paper page
- Kato S, 2007, Cancer Sci, 98, 790, 10.1111/j.1349-7006.2007.00478.x · doi:10.1111/j.1349-7006.2007.00478.x
- Keku TO, 2013, Trends Microbiol, 21, 506, 10.1016/j.tim.2013.08.004 · DOI
- Knolle P, 2001, Trends Immunol, 22, 432, 10.1016/S1471-4906(01)01957-3 · DOI · Paper page
- Kohatsu L, 2006, J Immunol, 177, 4718, 10.4049/jimmunol.177.7.4718 · DOI · Paper page
- Krogh P, 1987, Carcinogenesis, 8, 1543, 10.1093/carcin/8.10.1543 · DOI · Paper page
- Krogh P, 1987, Oral Surg Oral Med Oral Pathol, 63, 48, 10.1016/0030-4220(87)90339-2 · doi:10.1016/0030-4220(87)90339-2
- Krogh P, 1990, Acta Odontol Scand, 48, 85, 10.3109/00016359009012738 · DOI
- 10.4049/jimmunol.0902477 · DOI · Paper page
- Kurihara K, 2003, Biol Pharm Bull, 26, 233, 10.1248/bpb.26.233 · doi:10.1248/bpb.26.233
- Lalla RV, 2010, Support Care Cancer, 18, 985, 10.1007/s00520-010-0892-z · DOI · Paper page
- Lamaris GA, 2008, Eur J Clin Microbiol Infect Dis, 27, 343, 10.1007/s10096-007-0443-9 · DOI
- 10.1016/j.it.2007.03.006 · DOI
- 10.1053/jcrc.2002.35815 · DOI · Paper page
- Lim CSY, 2011, Int J Med Microbiol, 301, 536, 10.1016/j.ijmm.2010.12.002 · DOI
- Limmer A, 2001, Arch Immunol Ther Exp (Warsz.), 49, S7
- Manzo-Avalos S, 2010, Int J Environ Res Public Health, 7, 4281, 10.3390/ijerph7124281 · DOI · Paper page
- Marttila E, 2013, Mol Oral Microbiol, 28, 281, 10.1111/omi.12024 · DOI
- Matsuda K, 2009, J Vet Med Sci, 71, 229, 10.1292/jvms.71.229 · doi:10.1292/jvms.71.229
- 10.1371/journal.pone.0038584 · DOI · Paper page
- 10.1371/journal.pone.0053653 · DOI · Paper page
- McGeachy MJ, 2012, J Immunol, 189, 3285, 10.4049/jimmunol.1201834 · DOI · Paper page
- 10.1093/glycob/cwj077 · DOI · Paper page
- 10.1084/jem.20082109 · DOI
- Mendoza L, 1998, J Cell Physiol, 174, 322, 10.1002/(SICI)1097-4652(199803)174:3<322::AID-JCP6>3.0.CO;2-Q · DOI · Paper page
- 10.1016/j.chom.2014.02.011 · DOI · Paper page
- Meurman JH, 2008, Acta Odontol Scand, 66, 321, 10.1080/00016350802446527 · DOI
- 10.1128/IAI.00840-08 · DOI · Paper page
- 10.1128/CMR.00046-08 · DOI · Paper page
- 10.3402/jom.v2i0.5780 · DOI · Paper page
- Moore B, 1998, Angiogenesis, 2, 123, 10.1023/A:1009284305061 · DOI
- Mueller V, 2007, J Immunol, 179, 8435, 10.4049/jimmunol.179.12.8435 · DOI · Paper page
- 10.1371/journal.pone.0026240 · DOI
- 10.1016/j.autrev.2011.10.007 · DOI
- 10.1086/340511 · DOI · Paper page
- 10.4049/jimmunol.172.6.3712 · DOI · Paper page
- 10.1172/JCI27114 · DOI · Paper page
- 10.1111/j.1574-695X.2007.00353.x · DOI · Paper page
- 10.1016/j.it.2010.06.007 · DOI
- 10.1016/j.oraloncology.2009.08.002 · DOI
- Norgaard M, 2013, Eur J Intern Med, 24, 451, 10.1016/j.ejim.2013.02.017 · DOI
- 10.1086/432060 · DOI · Paper page
- Ogrady JF, 1992, Carcinogenesis, 13, 783, 10.1093/carcin/13.5.783 · DOI
- Onoe T, 2005, Transplant Int, 18, 206, 10.1111/j.1432-2277.2004.00025.x · DOI
- 10.1128/IAI.68.3.1134-1141.2000 · DOI · Paper page
- 10.1128/EC.00165-09 · DOI · Paper page
- 10.1002/ijc.21731 · DOI · Paper page
- Parvez T, 2003, J Coll Physicians Surg Pak, 13, 669
- Pemán J, 2002, Rev Iberoam Micol, 19, 30
- 10.1093/infdis/jir867 · DOI · Paper page
- Poikonen E, 2010, BMC Infect Dis, 10, 312, 10.1186/1471-2334-10-312 · DOI · Paper page
- 10.1093/alcalc/agh057 · DOI · Paper page
- Rafailidis PI, 2008, Eur J Clin Microbiol Infect Dis, 27, 753, 10.1007/s10096-008-0488-4 · doi:10.1007/s10096-008-0488-4
- Ramirez-Garcia A, 2011, Appl Microbiol Biotechnol, 92, 133, 10.1007/s00253-011-3540-8 · DOI
- 10.1371/journal.pone.0053584 · DOI
- Ramoner R, 2010, Cancer Immunol Immunother, 59, 1141, 10.1007/s00262-010-0827-z · DOI
- 10.1084/jem.20082818 · DOI · Paper page
- Rodriguez-Cuesta J, 2005, Clin Exp Metastasis, 22, 549, 10.1007/s10585-005-5261-9 · DOI
- Rodriguez-Cuesta J, 2010, Clin Exp Metastasis, 27, 35, 10.1007/s10585-009-9300-9 · DOI
- Ruhnke M, 2002, Eur J Med Res, 7, 227
- 10.1016/j.immuni.2010.05.001 · DOI · Paper page
- Sanjaya PR, 2011, Med Hypotheses, 77, 1125, 10.1016/j.mehy.2011.09.018 · DOI
- 10.1016/j.canlet.2010.09.011 · DOI
- Sawyer R, 1976, Infect Immun, 14, 1348, 10.1128/IAI.14.6.1348-1355.1976 · DOI
- Schlesinger A, 2009, Lancet Infect Dis, 9, 97, 10.1016/S1473-3099(08)70284-6 · DOI
- 10.1371/journal.pone.0039633 · DOI
- Seitz HK, 2007, Novartis Found Symp, 285, 110, 10.1002/9780470511848.ch8 · doi:10.1002/9780470511848.ch8
- 10.1038/nrc2191 · DOI · Paper page
- 10.1007/s12263-009-0154-1 · DOI · Paper page
- 10.1002/ijc.24467 · DOI
- Sohrabi N, 2010, Can J Microbiol, 56, 771, 10.1139/W10-064 · DOI
- 10.1016/j.semcancer.2003.10.006 · DOI · Paper page
- 10.1016/j.cytogfr.2005.04.007 · DOI · Paper page
- 10.1038/ni1408 · DOI · Paper page
- Tepes B, 2009, J Physiol Pharmacol, 60, 71
- Tillonen J, 1999, Alcohol Clin Exp Res, 23, 1409, 10.1111/j.1530-0277.1999.tb04364.x · DOI
- 10.1371/journal.ppat.1002379 · DOI · Paper page
- 10.1016/j.ijantimicag.2006.01.002 · DOI · Paper page
- Uittamo J, 2009, Int J Cancer, 124, 754, 10.1002/ijc.23976 · DOI
- van der Graaf C, 2005, Infect Immun, 73, 7458, 10.1128/IAI.73.11.7458-7464.2005 · DOI · Paper page
- van der Waal I, 2010, Oral Oncol, 46, 423, 10.1016/j.oraloncology.2010.02.016 · DOI · Paper page
- 10.1073/pnas.97.2.734 · DOI · Paper page
- 10.1016/j.micinf.2003.09.020 · DOI · Paper page
- 10.1128/IAI.73.8.4588-4595.2005 · DOI · Paper page
- Wang F, 2009, Curr Opin Pharmacol, 9, 389, 10.1016/j.coph.2009.06.005 · DOI
- 10.4049/jimmunol.180.11.7404 · DOI · Paper page
- Williamson DM, 1969, Br J Dermatol, 81, 125, 10.1111/j.1365-2133.1969.tb15992.x · DOI · Paper page
- 10.1080/13693780701377162 · DOI · Paper page
- Zirkel J, 2012, Med Mycol, 50, 50, 10.3109/13693786.2011.587211 · DOI · Paper page
Cited by
A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors
Dohlman, A. B., Klug, J., Mesko, M., Gao, I. H., Lipkin, S. M., Shen, X., & Iliev, I. D. (2022) · Cell · doi:10.1016/j.cell.2022.09.015 · Cited by 413
The oral microbiota and its role in carcinogenesis
Stasiewicz, M., & Karpiński, T. M. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.11.002 · Cited by 282
Diabetes and Cancer: Risk, Challenges, Management and Outcomes
Shahid, R. K., Ahmed, S., Le, D., & Yadav, S. (2021) · Cancers · doi:10.3390/cancers13225735 · Cited by 187
“In addition, there is emerging evidence that certain infection such as candidiasis, which is more common patients with diabetes, has been associated with an increased risk of cancer [37,41,42].”
BackgroundThe microbiome and the hallmarks of cancer
Fulbright, L. E., Ellermann, M., & Arthur, J. C. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006480 · Cited by 164
(2022) · doi:10.1016/j.hsr.2021.100010 · Cited by 69
Metadata
- Authors
- Ramirez-Garcia, A., Rementeria, A., Aguirre-Urizar, J. M., Moragues, M. D., Antoran, A., Pellon, A., Abad-Diaz-de-Cerio, A., & Hernando, F. L.
- Venue
- Critical Reviews in Microbiology
- Publisher
- Informa UK Limited
- Published
- 2014-06-25
- Volume
- 42
- Issue
- 2
- Pages
- 1-13
- ISSN
- 1040-841X (ISSN-L)
- 1549-7828
- OpenAlex
- W2090893706
- Cited by
- 119
- References
- 26
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Candida albicans and cancer: Can this yeast induce cancer development or progression? https://app.cochat.ai/papers/10.3109/1040841x.2014.913004
- The paper
- Ramirez-Garcia, A., Rementeria, A., Aguirre-Urizar, J. M., Moragues, M. D., Antoran, A., Pellon, A., Abad-Diaz-de-Cerio, A., & Hernando, F. L. (2014). Candida albicans and cancer: Can this yeast induce cancer development or progression? Critical Reviews in Microbiology. https://doi.org/10.3109/1040841x.2014.913004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.